BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35236635)

  • 21. Spindle cell tumours of the breast: practical approach to diagnosis.
    Al-Nafussi A
    Histopathology; 1999 Jul; 35(1):1-13. PubMed ID: 10383708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal Anomalous Expression of Cytokeratin and p63 in Malignant Phyllodes Tumor: A Comparison With Spindle Cell Metaplastic Carcinoma.
    Bansal M; Chen J; Wang X
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):198-201. PubMed ID: 28968268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights.
    Rungta S; Kleer CG
    Arch Pathol Lab Med; 2012 Aug; 136(8):896-900. PubMed ID: 22849737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
    Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
    Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spindle cell lesions of the breast--the pathologic differential diagnosis.
    Tse GM; Tan PH; Lui PC; Putti TC
    Breast Cancer Res Treat; 2008 May; 109(2):199-207. PubMed ID: 17636400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent MED12 mutations in phyllodes tumours of the breast.
    Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
    Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
    Zhou P; Zhang Q; Zhu J; Li P
    Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spindle cell carcinoma of the breast : diagnostic difficulties].
    Lahbali O; Azami A; Mahdi Y; El Khannoussi B
    Rev Med Brux; 2018; 39(3):142-145. PubMed ID: 29869473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spindle cell lesions of the breast: a diagnostic approach.
    Rakha EA; Brogi E; Castellano I; Quinn C
    Virchows Arch; 2022 Jan; 480(1):127-145. PubMed ID: 34322734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
    Yang G; Guo L; Jin H; Li J; Ding H
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis.
    Liu J; Li F; Liu X; Lang R; Liang R; Lu H
    Breast Cancer Res Treat; 2023 Jun; 199(3):435-444. PubMed ID: 37071267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation between metaplastic carcinomas and sarcomas of the human female breast by fibronectin.
    Christensen L; Nielsen M; Hølund B; Clemmensen I
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):465-76. PubMed ID: 2996215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.
    Yoshida M; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Hiraoka N; Sekine S
    Br J Cancer; 2015 Oct; 113(8):1244-8. PubMed ID: 26355235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An approach to the diagnosis of spindle cell lesions of the breast.
    Rakha EA; Aleskandarany MA; Lee AH; Ellis IO
    Histopathology; 2016 Jan; 68(1):33-44. PubMed ID: 26768028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast.
    Wang J; Wang WL; Sun H; Huo L; Wu Y; Chen H; Gan Q; Meis JM; Maloney N; Lazar AJ; Yoon EC; Albarracin CT; Krishnamurthy S; Middleton LP; Resetkova E; Yu W; Tan D; Lu W; Solis Soto LM; Wang S; Wistuba II; Parwani AV; Prieto VG; Sahin AA; Li Z; Ding Q
    Hum Pathol; 2022 Mar; 121():73-80. PubMed ID: 35063444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.
    Vranic S; Stafford P; Palazzo J; Skenderi F; Swensen J; Xiu J; Spetzler D; Gatalica Z
    Clin Breast Cancer; 2020 Aug; 20(4):326-331.e1. PubMed ID: 32197944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cancer stem cell markers in breast phyllodes tumor.
    Kim SI; Koo JS
    Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases.
    Noronha Y; Raza A; Hutchins B; Chase D; Garberoglio C; Chu P; Weiss L; Wang J
    Int J Surg Pathol; 2011 Apr; 19(2):152-8. PubMed ID: 21087983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and molecular markers in breast phyllodes tumors.
    Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.